Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chemoradiotherapy of NSCLC Stage IIIB

This study has been completed.
Bristol-Myers Squibb
Pierre Fabre Laboratories
Ligue contre le cancer, France
Information provided by:
Intergroupe Francophone de Cancerologie Thoracique Identifier:
First received: September 13, 2005
Last updated: March 9, 2016
Last verified: March 2016